SPL 2.63% 9.8¢ starpharma holdings limited

CEO of Starpharma interviewed by Alan Kohler, page-2

  1. 615 Posts.
    lightbulb Created with Sketch. 93
    Just read it. Thanks a lot Antibotter.
    Much appreciated.

    I did not like her answer about us never being approached for a takeover. If our DEP formula is a game changer, a patent revival, a better drug delivery system to all drugs .... why nobody even tried to approach us.

    Also, viraleze. To be able to really conquer the world and not be a second class nasal product that is sitting there on shelves.... it should be branded and distributed by a big pharma. Even in parallel w their vaccine. Just imagine pfizer or azn or J&J or Eli Lilly distributing it. Or giving it along with each vaccine.

    Too weak. Hope i am wrong.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.8¢
Change
0.003(2.63%)
Mkt cap ! $40.20M
Open High Low Value Volume
9.8¢ 9.8¢ 9.8¢ $29.11K 297.1K

Buyers (Bids)

No. Vol. Price($)
5 546484 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 10000 1
View Market Depth
Last trade - 10.24am 24/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.